Skip to main content

Ligand Pharmaceuticals Inc

LGND
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000886163

In the last 90 days, Ligand Pharmaceuticals Inc insiders filed 0 open-market purchases and 6 sales; 417 institutions reported holding it in 13F filings for Q2 2026, worth $7.15B in total; no superinvestor holds it.

Other share classesLGNDZLGNXZLGNYZLGNZZ

13F holders, Q1 2024

Institutional positions in Ligand Pharmaceuticals Inc as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
222
+14 vs. Q4 2023
Shares held
16.5M
+447.3K (+2.8%) vs. Q4 2023
Total value
$1.21B
+$59.4M (+5.2%) vs. Q4 2023
New holders
33
64 more added
Sold out
19
71 more reduced

3 institutions that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting LGND on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2024: 222 institutions
Q1 2021: 228 institutionsQ2 2021: 212 institutionsQ3 2021: 208 institutionsQ4 2021: 221 institutionsQ1 2022: 207 institutionsQ2 2022: 198 institutionsQ3 2022: 205 institutionsQ4 2022: 198 institutionsQ1 2023: 213 institutionsQ2 2023: 204 institutionsQ3 2023: 197 institutionsQ4 2023: 211 institutionsQ1 2024: 222 institutionsQ2 2024: 235 institutionsQ3 2024: 243 institutionsQ4 2024: 259 institutionsQ1 2025: 262 institutionsQ2 2025: 271 institutionsQ3 2025: 314 institutionsQ4 2025: 351 institutionsQ1 2026: 359 institutionsQ2 2026: 417 institutions
Value heldQ1 2024: $1.21B
Q1 2021: $2.35BQ2 2021: $2.09BQ3 2021: $2.29BQ4 2021: $2.51BQ1 2022: $1.76BQ2 2022: $1.33BQ3 2022: $1.28BQ4 2022: $983.5MQ1 2023: $1.10BQ2 2023: $1.12BQ3 2023: $946.5MQ4 2023: $1.15BQ1 2024: $1.21BQ2 2024: $1.45BQ3 2024: $1.81BQ4 2024: $1.96BQ1 2025: $1.97BQ2 2025: $2.18BQ3 2025: $3.63BQ4 2025: $3.89BQ1 2026: $4.15BQ2 2026: $7.15B
Institutions holding LGND and their total value by quarter
QuarterHoldersValue
Q2 2026417$7.15B
Q1 2026359$4.15B
Q4 2025351$3.89B
Q3 2025314$3.63B
Q2 2025271$2.18B
Q1 2025262$1.97B
Q4 2024259$1.96B
Q3 2024243$1.81B
Q2 2024235$1.45B
Q1 2024222$1.21B
Q4 2023211$1.15B
Q3 2023197$946.5M
Q2 2023204$1.12B
Q1 2023213$1.10B
Q4 2022198$983.5M
Q3 2022205$1.28B
Q2 2022198$1.33B
Q1 2022207$1.76B
Q4 2021221$2.51B
Q3 2021208$2.29B
Q2 2021212$2.09B
Q1 2021228$2.35B

Institutions, Q1 2024

Shares, value and share of portfolio for each institution holding Ligand Pharmaceuticals Inc; share changes are against Q4 2023.

Institutions holding LGND in Q1 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Bank of America Corp149,738$10.9M0.00%+37,038+32.9%Added
Charles Schwab Investment Management Inc149,776$10.9M0.00%−11,704−7.2%Reduced
William Blair Investment Management, LLC189,247$13.8M0.04%+1,905+1.0%Added
Ashford Capital Management Inc196,535$14.4M1.94%+196,535New
Northern Trust Corp210,286$15.4M0.00%−9,494−4.3%Reduced
Invesco Ltd.215,095$15.7M0.00%+194+0.1%Added
Chicago Capital, LLC229,596$16.8M0.51%−1,915−0.8%Reduced
Deutsche Bank AG235,904$17.2M0.01%+50,007+26.9%Added
Morgan Stanley251,897$18.4M0.00%+52,703+26.5%Added
Impax Asset Management Group plc255,208$18.7M0.07%+50,000+24.4%Added
Rice Hall James & Associates, LLC279,784$20.5M1.17%+3,776+1.4%Added
Standard Life Aberdeen plc281,556$20.6M0.04%−8,862−3.1%Reduced
Geode Capital Management, LLC380,970$27.9M0.00%+10,155+2.7%Added
Villere St Denis J & Co LLC490,752$35.9M2.86%+62,701+14.6%Added
Cardinal Capital Management LLC559,235$40.9M2.05%+337,308+152.0%Added
Dimensional Fund Advisors LP664,081$48.5M0.01%+2,783+0.4%Added
State Street Corp671,284$49.1M0.00%+3,000+0.4%Added
Stephens Investment Management Group LLC696,758$50.9M0.68%+37,324+5.7%Added
Janus Henderson Group PLC1,008,477$73.7M0.04%−334,677−24.9%Reduced
Macquarie Group Ltd1,033,181$75.5M0.09%+45,827+4.6%Added
Vanguard Group Inc1,884,112$137.7M0.00%+7,598+0.4%Added
BlackRock Inc.2,868,270$209.7M0.00%−94,044−3.2%Reduced
Pacer Advisors, Inc.0$00.00%−325,727−100.0%Sold out
Kennedy Capital Management, Inc.0$00.00%−33,853−100.0%Sold out
Caxton Associates LP0$00.00%−18,250−100.0%Sold out
Skandinaviska Enskilda Banken AB (publ)0$00.00%−18,000−100.0%Sold out
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main0$00.00%−12,859−100.0%Sold out
Brown Advisory Inc0$00.00%−7,757−100.0%Sold out
Atom Investors LP0$00.00%−4,999−100.0%Sold out
Gotham Asset Management, LLC0$00.00%−4,183−100.0%Sold out
Versor Investments LP0$00.00%−3,848−100.0%Sold out
Two Sigma Investments, LP0$00.00%−3,000−100.0%Sold out
Advisor Resource Council0$00.00%−2,804−100.0%Sold out
State of Wyoming0$00.00%−1,288−100.0%Sold out
Group One Trading, L.P.0$00.00%−916−100.0%Sold out
Johnson Financial Group, Inc.0$00.00%−130−100.0%Sold out
Advisory Services Network, LLC0$00.00%−112−100.0%Sold out
DAGCO, Inc.0$00.00%−84−100.0%Sold out
Luken Investment Analytics, LLC0$00.00%−50−100.0%Sold out
Larson Financial Group LLC0$00.00%−20−100.0%Sold out
Ronald Blue Trust, Inc.0$00.00%−5−100.0%Sold out
Smith, Graham & Co., Investment Advisors, LP––––Not filed
Putnam Investments LLC––––Not filed
Spouting Rock Asset Management, LLC––––Not filed